Purchase Order 36C25625P0060

Award Date 10/8/24
Potential Completion Date 1/1/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70119, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
This is a firm-fixed price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, worth $49,748.73, is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers nationwide. The award is not associated with a...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company. The contract has a potential value of $99,173.46 and is to provide Novocure's Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services to VA medical centers and facilities nationwide. Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducer arrays, and related equipment rentals and support services for the treatment of solid tumor cancers, including glioblastoma, for veterans at VA medical centers and clinics. The contract has a potential value of $103,914.55 and a...
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) delivery systems, transducer arrays, rentals, and support services to VA medical centers. This $126,000.00 order was placed by the VA VHA Veterans Integrated Service Network (VISN) 23 and is for services to be performed in Portsmouth, New Hampshire. Novocure is the...
This $49,748.73 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure holds a 5-year Federal Supply Schedule contract with the VA VHA...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $12,216.60 contract is for the provision of Novocure's proprietary Optune line of Tumor Treating Fields (TTFields) cancer therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure holds a 5-year $28.85...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the delivery of Optune Plus Transducers, which are part of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is not set aside and is part of a larger $28.85...

This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This order is issued under Novocure's existing 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which was awarded in November 2022. The contract does not utilize any set-aside designations, likely due to the specialized nature of Novocure's cancer treatment technologies. Novocure acts as the prime contractor, delivering its proprietary Optune TTFields therapy products and services directly to VA medical centers nationwide to support the VA's mission of expanding veterans' access to cutting-edge cancer therapies.

Generated 1/14/25, 9:11 AM